Travere therapeutics to present at the 11th annual svb leerink global healthcare conference

San diego, feb. 09, 2022 (globe newswire) -- travere therapeutics, inc. (nasdaq: tvtx) today announced that eric dube, ph.d., chief executive officer, will present at the virtual 11th annual svb leerink global healthcare conference on thursday, february 17, 2022 at 2:20 p.m. et.

TVTX Ratings Summary

TVTX Quant Ranking